Adicet Bio (ACET)
(Delayed Data from NSDQ)
$0.67 USD
-0.02 (-2.19%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $0.66 -0.01 (-1.58%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ACET 0.67 -0.02(-2.19%)
Will ACET be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ACET based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACET
Adicet Bio (ACET) Upgraded to Buy: Here's What You Should Know
ACET: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ACET
Adicet Bio (ACET) Advances Phase 1 Trial for Autoimmune Treatment | ACET Stock News
Adicet Bio doses first patient in second cohort of ADI-001 trial
Adicet Bio Announces First Systemic Sclerosis (SSc) Patient Dosed in Ongoing Phase 1 Clinical ...
Adicet Bio (ACET) Receives Buy Rating from HC Wainwright & Co. | ACET Stock News
ACET Stock Potential Boosted by New Analyst Coverage | ACET Stock News